Summary
A total of 26 women who submitted to cisplatin chemotherapy received as antiemetic treatment a combination of metoclopramide, dexamethasone and diphenhydramine. Acupuncture according to traditional Chinese medicine was also carried out. The results were compared with those obtained in a similar group of women with cancer, who were treated in the same setting with the same antiemetic combination but without additional acupuncture. Acupuncture was shown to increase complete protection from nausea and to decrease the intensity and duration of nausea and vomiting. However, the difficulties of performing acupuncture routinely in daily practice are a hindrance to its wider use.
References
Dundee JW, Ghaly RG, Fitzpatrick KTJ, Lynch GA, Abram WP (1987) Acupuncture to prevent cisplatin-associated vomiting. Lancet I: 1083
Roila F, Tonato M, Basurto C, Bella M, Passalacqua R, Morsia D, Di Costanzo F, Donati D, Ballatori E, Tognoni G, Franzosi MG, Del Favero A (1987) Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research. J Clin Oncol 5: 141–149
Roila F, Tonato M, Basurto C, Picciafuoco M, Bracarda S, Donati D, Malacarne P, Monici L, Di Costanzo F, Patoia L, Ballatori E, Tognoni G, Del Favero A (1989) Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: A study of the Italian Oncology Group for Clinical Research. J Clin Oncol 7: 1693–1700
Author information
Authors and Affiliations
Additional information
Supported by a grant from the Associazione Umbra per la lotta contro il Cancro (AUCC)
Rights and permissions
About this article
Cite this article
Aglietti, L., Roila, F., Tonato, M. et al. A pilot study of metoclopramide, dexamethasone, diphenhydramine and acupuncture in women treated with cisplatin. Cancer Chemother Pharmacol 26, 239–240 (1990). https://doi.org/10.1007/BF02897209
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02897209